Early Aggressive Treatment
Early aggressive treatment applies to the strategy of treating MS with an aggressive treatment to prevent potential damage, as soon as possible after the onset of the disease. This strategy is viewed as being riskier than using 1st-line DMTs that are safer, but less, effective than treatments used for early aggressive treatment. The data from this survey was used as part of a presentation at the European Charcot Foundation Meeting in Spain on the 29th November to the 1st December 2012. I would now like to expand this survey so that I can use the data as part of a presentation to the European Medicines Agency on the 17th October 2013.